What if there was a medication that could treat not just one, but multiple devastating diseases: leukemia, Alzheimer’s and dementia, and Parkinson’s? At Georgetown University Medical Center, researchers are hopeful that nilotinib is that medication. Now approved to be used in those with one type of leukemia, a small trial is producing great excitement in its promising results to clear the brain of toxic proteins. Georgetown’s medical director of the…